1 follower
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Gameto
4 followers
Synthekine
3 followers
Tango Therapeutics
2 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Apogee Therapeutics
1 follower
Cargo
1 follower
Aura Biosciences
1 follower
Explore companies